Breaking News: Garden Stage Limited Receives Nasdaq Notification Letter for Minimum Bid Price Deficiency!

Hong Kong, Dec. 30, 2024 (GLOBE NEWSWIRE) —

Garden Stage Limited (NASDAQ: GSIW) (“GSIW” or the “Company”), today announced that it received a delinquency notification letter (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) on December 24, 2024 indicating that the Company is not currently in compliance with the minimum bid price requirement set forth in Nasdaq’s Listing Rules for continued listing on the Nasdaq Capital Market, as the closing bid price for the Company’s ordinary shares listed on the Nasdaq Capital Market was below $1.00 per share for 30 consecutive business days. Nasdaq Listing Rule 5550(a)(2) requires listed securities to maintain a minimum bid price of $1.00 per share, and Nasdaq Listing Rule 5810(c)(3)(A) provides that a failure to meet the minimum bid price requirement exists if the deficiency continues for a period of 30 consecutive business days. The Notice provides that the Company has a period of 180 calendar days from the date of the Notice, or until June 23, 2025, to regain compliance with the minimum bid price requirement.

As a shareholder or potential investor in Garden Stage Limited, this news may have a significant impact on your investment. The minimum bid price deficiency could lead to potential delisting from the Nasdaq Capital Market, causing a decrease in the liquidity and marketability of the company’s shares. It is essential to closely monitor the company’s actions to regain compliance before the deadline to make informed decisions regarding your investment.

In the broader context, Garden Stage Limited receiving a Nasdaq notification letter for minimum bid price deficiency reflects the challenging economic conditions or internal operational issues the company may be facing. This news could impact the confidence of other investors and stakeholders in the company’s ability to meet financial requirements and maintain regulatory compliance. It also highlights the importance of regulatory standards and transparency in the financial markets to ensure fair and orderly trading for all participants.

Conclusion

In conclusion, Garden Stage Limited’s receipt of the Nasdaq notification letter for minimum bid price deficiency raises concerns for shareholders and the broader financial community regarding the company’s financial health and compliance with regulatory requirements. It is crucial for the company to take prompt and effective measures to address the deficiency and regain compliance within the specified timeline to mitigate potential negative consequences associated with non-compliance. As investors, it is recommended to stay informed about the company’s progress in resolving the issue and consider the implications for your investment decisions.